Skip to main content
Caplight Logo









Biomedican

Biomedican

Private
Fremont, CaliforniaHealthcare & Life Scienceshttps://biomedican.com/

Last Round

Crowdfunding

Oct 1, 2021

Total Funding Raised

$3M

Company Overview

Biomedican operates in Healthcare & Life Sciences and is based in Fremont, California. Its latest recorded funding round was a Crowdfunding round in October 2021.

Biomedican is a biotechnology company that designs patented low-cost methods of growing high-value compounds, such as rare cannabinoids and astaxanthin, at scale using proprietary yeast fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Biomedican Comparables

Compare Biomedican with similar companies based on industry and business-model similarity.

Biomedican comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hyasynth Biologicals Inc.
93%
Creo
88%
Cellibre
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Biomedican Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingOct 1, 2021
Early FundingOct 11, 2019
Early FundingJan 29, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 50% MoM.

  • Jan 5, 2026

    Monthly visitors grew 76% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Biomedican Filings

Explore SEC and related filing metadata, where available.

Biomedican filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Biomedican's valuation, stock price, and market status.

Is Biomedican a public or private company?

Biomedican is a private company.

What is the current stock price of Biomedican?

Biomedican is a private company, so its shares have no public market price. Caplight tracks Biomedican's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Biomedican worth (valuation)?

Valuation information for Biomedican is not publicly available.

Can I buy Biomedican stock?

Biomedican shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Biomedican's last funding round?

Biomedican's most recent funding round was Crowdfunding on October 1, 2021.

Who are the main investors in Biomedican?

Investor information for Biomedican is not publicly disclosed.

Will Biomedican IPO soon?

No public IPO plans have been announced for Biomedican.

How can I track Biomedican secondary market activity?

Caplight tracks bids, offers, and trades in Biomedican's shares on secondary markets.

Firmographic Details

HeadquartersFremont, California
Employee Range12
Year Founded2017
Last FundingOct 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?